JUN and Alzheimer disease: Since DLK inhibition was the most protective compound, and we also see JNK inhibition (AS601245) was also protective to a less extend in our focused screens in both double and triple cultures, we sought to validate this pathway and investigate whether the DLK-JNK-cJun signaling pathway is activated in our AD model.